Literature DB >> 11290755

Cutting edge: characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection.

A Moris1, V Teichgräber, L Gauthier, H J Bühring, H G Rammensee.   

Abstract

The vast majority of alloreactive T cells recognize foreign MHC molecules in a peptide-dependent manner. A subpopulation of these peptide-dependent alloreactive T cells is peptide-specific and contains T cells that are of interest for tumor immunotherapy. Allorestricted T cells (i.e., peptide-specific and alloreactive) specific for tumor-associated Ags can be raised in vitro. However, it is technically difficult to distinguish between peptide-specific and peptide-nonspecific alloreactive T cells by functional assays in vitro. Here we show for the first time that allorestricted T cells specifically bind HLA-peptide tetrameric complexes, as nominal Ag-specific T cells would do. In consequence, fluorescent HLA-peptide tetrameric complexes can be used for sorting and cloning of allorestricted CTLs specific for a peptide of interest. We also show by the mean of HLA-peptide tetramers the existence of peptide-selective alloreactive T cells that recognize a conformation on the foreign-MHC brought about by some but not all peptides bound.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290755     DOI: 10.4049/jimmunol.166.8.4818

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Cytotoxic herpes simplex type 2-specific, DQ0602-restricted CD4 T+-cell clones show alloreactivity to DQ0601.

Authors:  Sandra Reichstetter; Nathan E Standifer; Kelly A Geubtner; Andrew W Liu; Stacy L Agar; William W Kwok
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

Review 2.  Alloimmune T cells in transplantation.

Authors:  Susan DeWolf; Megan Sykes
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

3.  Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.

Authors:  David Schirmer; Thomas G P Grünewald; Richard Klar; Oxana Schmidt; Dirk Wohlleber; Rebeca Alba Rubío; Wolfgang Uckert; Uwe Thiel; Felix Bohne; Dirk H Busch; Angela M Krackhardt; Stefan Burdach; Günther H S Richter
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

4.  Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function.

Authors:  Pierre S Rohrlich; Nicolas Fazilleau; Florent Ginhoux; Hüseyin Firat; Frédérique Michel; Madeleine Cochet; Nihay Laham; Marie Paule Roth; Steve Pascolo; Faridabano Nato; Hélène Coppin; Pierre Charneau; Olivier Danos; Oreste Acuto; Rachel Ehrlich; Jean Kanellopoulos; François A Lemonnier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-25       Impact factor: 11.205

Review 5.  Tricks with tetramers: how to get the most from multimeric peptide-MHC.

Authors:  Linda Wooldridge; Anna Lissina; David K Cole; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

6.  Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells.

Authors:  U Thiel; S Pirson; C Müller-Spahn; H Conrad; D H Busch; H Bernhard; S Burdach; G H S Richter
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

7.  MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy.

Authors:  Georg Dössinger; Mario Bunse; Jeannette Bet; Julia Albrecht; Paulina J Paszkiewicz; Bianca Weißbrich; Isabell Schiedewitz; Lynette Henkel; Matthias Schiemann; Michael Neuenhahn; Wolfgang Uckert; Dirk H Busch
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.